PEDIATRICS Vol. 49 No. 4 April 1972, pp. 631-632
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caplinger, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caplinger, K. J.

Aminophylline in Status Asthmaticus: Some Questions

Kelsy J. Caplinger M.D.1

1 Arkansas Allergy Clinic, P.A., P.O. Box 7008, Little Rock, Arkansas 72205

The report of a double blind trial of aminophylline in status asthmaticus by Pierson, et al. seems indeed to have shown that significant improvement in ventilatory function resulted without serious side effects.

Aminophylline toxicity is a very real and potentially serious complication of the treatment of status asthmaticus. There is a wide variation in the recommended children's dose of aminophylline. Since this study showed apparent good improvement in ventilatory function (when used with other accepted medications in appropriate doses) and serious side effects were avoided, it would be of interest to know the dose of aminophylline required in these patients.